HK1139942A1 - Atropisomer of pyrrole derivative - Google Patents

Atropisomer of pyrrole derivative

Info

Publication number
HK1139942A1
HK1139942A1 HK10106582.9A HK10106582A HK1139942A1 HK 1139942 A1 HK1139942 A1 HK 1139942A1 HK 10106582 A HK10106582 A HK 10106582A HK 1139942 A1 HK1139942 A1 HK 1139942A1
Authority
HK
Hong Kong
Prior art keywords
atropisomer
pyrrole derivative
alkyl group
prophylactic
hydroxy
Prior art date
Application number
HK10106582.9A
Other languages
English (en)
Inventor
Kazumasa Aoki
Hiroyuki Tsuruoka
Noriyuki Hayashi
Juri Yoshida
Yusuke Asoh
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1139942A1 publication Critical patent/HK1139942A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10106582.9A 2007-04-09 2010-07-07 Atropisomer of pyrrole derivative HK1139942A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007101938 2007-04-09
PCT/JP2008/056907 WO2008126831A1 (ja) 2007-04-09 2008-04-08 ピロール誘導体のアトロプ異性体

Publications (1)

Publication Number Publication Date
HK1139942A1 true HK1139942A1 (en) 2010-09-30

Family

ID=39863928

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10106582.9A HK1139942A1 (en) 2007-04-09 2010-07-07 Atropisomer of pyrrole derivative

Country Status (15)

Country Link
US (2) US8524918B2 (ja)
EP (1) EP2133330B1 (ja)
JP (1) JP5363312B2 (ja)
KR (2) KR20140048337A (ja)
CN (1) CN101679243B (ja)
BR (1) BRPI0809656B8 (ja)
CA (1) CA2683059C (ja)
DK (1) DK2133330T3 (ja)
ES (1) ES2448498T3 (ja)
HK (1) HK1139942A1 (ja)
IL (1) IL201261A0 (ja)
PL (1) PL2133330T3 (ja)
PT (1) PT2133330E (ja)
TW (1) TWI444185B (ja)
WO (1) WO2008126831A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102177137B (zh) * 2008-10-08 2015-03-18 埃克塞利希斯股份有限公司 1-苯基吡咯化合物
CA2736923C (en) 2008-10-08 2016-11-22 Exelixis Inc. Atropisomers of (hydroxyalkyl) pyrrole derivatives
WO2010098286A1 (ja) * 2009-02-25 2010-09-02 第一三共株式会社 ミネラルコルチコイド受容体拮抗薬を含有する医薬
JP5536869B2 (ja) * 2009-03-26 2014-07-02 ポクセル・エスアーエス 優先晶出法を利用したジヒドロ−１，３，５トリアジンラセミ体のエナンチオマー分離のための方法
BR112015025729B1 (pt) * 2013-04-10 2023-04-25 Daiichi Sankyo Company, Limited Métodos para resolver e para produzir um composto
ES2847904T3 (es) * 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicamento para la prevención o el tratamiento de la hipertensión
JP6422871B2 (ja) * 2013-08-27 2018-11-14 第一三共株式会社 ピロール誘導体の製造方法及びその中間体
DK3160948T3 (en) 2014-06-30 2019-02-18 Astrazeneca Ab BENZOXAZINONAMIDES AS MODULATORS OF MINERALOCORTICOID RECEPTORS
KR102488167B1 (ko) * 2015-01-26 2023-01-12 다이이찌 산쿄 가부시키가이샤 피롤카르복사미드의 고형 조성물
CN105985295B (zh) * 2015-02-17 2018-11-20 华润赛科药业有限责任公司 一种旋光纯的硫代乙酸类化合物
CN105622531A (zh) 2015-04-03 2016-06-01 南京明德新药研发股份有限公司 轴手性异构体及其制备方法和制药用途
WO2017064121A1 (en) 2015-10-13 2017-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of choroidal neovascularisation
EP3434284A4 (en) * 2016-03-24 2019-11-13 Daiichi Sankyo Company, Limited MEDICINE FOR THE TREATMENT OF KIDNEY DISEASE
EP3490606B8 (en) 2016-07-26 2024-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonist of mineralocorticoid receptor for the treatment of osteoarthritis
US20220211665A1 (en) * 2019-10-25 2022-07-07 Sunshine Lake Pharma Co., Ltd. Pyrrole amide compound and use thereof
EP4118235A1 (en) 2020-03-11 2023-01-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of determining whether a subject has or is at risk of having a central serous chorioretinopathy
CA3213094A1 (en) * 2021-03-30 2022-10-06 Qiao ZONG Crystalline form of pyrrole amide compound, preparation method therefor and use thereof
US20240239746A1 (en) * 2021-04-26 2024-07-18 Sunshine Lake Pharma Co., Ltd. Preparation method for pyrrole amide compound
EP4395785A1 (en) 2021-08-31 2024-07-10 Inserm (Institut National de la Santé et de la Recherche Scientifique) Methods for the treatment of ocular rosacea
CN115784961A (zh) * 2021-09-10 2023-03-14 上海鼎雅药物化学科技有限公司 埃沙西林酮及其中间体的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323208B1 (en) * 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
MXPA04002438A (es) * 2001-09-24 2004-06-29 Bayer Pharmaceuticals Corp Preparacion y uso de derivados de pirroll para el tratamiento de la obesidad.
US6939968B2 (en) * 2002-12-23 2005-09-06 Bristol-Myers Squibb Company Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
DE10354060A1 (de) * 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
PT1773768T (pt) * 2004-07-30 2018-11-30 Exelixis Inc Derivados de pirrol como agentes farmacêuticos
EP1844020B1 (en) * 2005-01-10 2017-09-06 Exelixis, Inc. Heterocyclic carboxamide compounds as steroid nuclear receptor ligands

Also Published As

Publication number Publication date
DK2133330T3 (da) 2014-03-31
BRPI0809656A2 (pt) 2014-10-07
US20140024696A1 (en) 2014-01-23
KR20090127421A (ko) 2009-12-11
EP2133330A4 (en) 2010-08-11
CA2683059C (en) 2012-09-25
PL2133330T3 (pl) 2014-06-30
PT2133330E (pt) 2014-03-31
WO2008126831A1 (ja) 2008-10-23
EP2133330B1 (en) 2014-01-01
TWI444185B (zh) 2014-07-11
EP2133330A1 (en) 2009-12-16
CN101679243A (zh) 2010-03-24
BRPI0809656B8 (pt) 2021-05-25
CA2683059A1 (en) 2008-10-23
JP5363312B2 (ja) 2013-12-11
US8754118B2 (en) 2014-06-17
CN101679243B (zh) 2012-09-26
KR20140048337A (ko) 2014-04-23
ES2448498T3 (es) 2014-03-14
TW200901968A (en) 2009-01-16
BRPI0809656B1 (pt) 2019-07-09
JPWO2008126831A1 (ja) 2010-07-22
US20100093826A1 (en) 2010-04-15
IL201261A0 (en) 2010-05-31
KR101477579B1 (ko) 2014-12-30
US8524918B2 (en) 2013-09-03

Similar Documents

Publication Publication Date Title
HK1139942A1 (en) Atropisomer of pyrrole derivative
MY148703A (en) Polycyclic cinnamide derivatives
TW200726470A (en) 6,7-unsaturated-7-carbamoylmorphinan derivatives
MY150507A (en) Polycyclic compound
WO2008108386A1 (ja) 医薬組成物
NZ592497A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
WO2007101060A3 (en) Compounds for the treatment of metabolic disorders
EA200870336A1 (ru) Полициклические производные циннамида
WO2007087505A3 (en) Compounds for the treatment of metabolic disorders
PT2192109E (pt) Derivado de -aminoácido bicíclico
WO2007137008A3 (en) Compounds for the treatment of metabolic disorders
WO2007060257A3 (en) Diketopyrrolo-pyrrole compounds
WO2007095462A3 (en) Compounds for the treatment of metabolic disorders
TN2009000024A1 (en) Prodrug of cinnamide compound
GB0719180D0 (en) New process
JO2871B1 (en) Perol compounds
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
IN2014CN00613A (ja)
HK1164114A1 (en) Antidepressant containing heterocyclic compound having specific structure
TW200637539A (en) CTGF inhibitors
WO2009047298A3 (en) Dimers of harmol or of its derivatives and uses thereof
MX2010001566A (es) Derivado de aminopirazolamida.
WO2007096740A3 (en) Novel cephalosporins
WO2007082262A3 (en) Novel compounds
TW200621241A (en) Process for the preparation of isothiazole derivatives